Logo for Keros Therapeutics Inc

Keros Therapeutics Investor Relations Material

Latest events

Logo for Keros Therapeutics Inc

Status Update

Keros Therapeutics
Logo for Keros Therapeutics

Q1 2025

6 May, 2025
Logo for Keros Therapeutics

Status Update

31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Keros Therapeutics Inc

Access all reports
Keros Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of novel treatments aimed at addressing unmet medical needs in hematological, pulmonary, and cardiovascular disorders. By leveraging cutting-edge science, Keros is focused on creating therapies that have the potential to significantly improve patient outcomes. The company's research and development efforts are grounded in the transformative potential of TGF-β (transforming growth factor-beta) science. It is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.